Refractory Cancer
specificA malignant neoplasm that does not respond to treatment.
41
Centers
56
Active Trials
$4M
Cancer Funding
Top Centers for Refractory Cancer(41)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive High-Volume Research Center | 85.8 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 71.5 |
| 3 | NCI Comprehensive Active Research Program | 68.7 |
| 4 | NCI Clinical Active Research Program | 68.7 |
| 5 | Boston University Cancer CenterBoston, MA Active Research Program | 68.7 |
| 6 | NCI Comprehensive Active Research Program | 64.5 |
| 7 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 61.0 |
| 8 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 61.0 |
| 9 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 61.0 |
| 10 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 61.0 |
| 11 | University of Illinois Cancer CenterChicago, IL Active Research Program | 61.0 |
| 12 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 61.0 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 61.0 |
| 14 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 61.0 |
| 15 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 61.0 |
| 16 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 61.0 |
| 17 | NCI Comprehensive Active Research Program | 49.3 |
| 18 | UK Markey Cancer CenterLexington, KY NCI Comprehensive Active Research Program | 47.6 |
| 19 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 45.7 |
| 20 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 45.7 |
| 21 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 45.7 |
| 22 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 45.7 |
| 23 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 45.7 |
| 24 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 45.7 |
| 25 | NCI Comprehensive Active Research Program | 45.7 |
| 26 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 45.7 |
| 27 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 45.7 |
| 28 | NCI Comprehensive Active Research Program | 45.7 |
| 29 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 45.7 |
| 30 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 45.7 |
| 31 | NCI Comprehensive Active Research Program | 45.7 |
| 32 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 45.7 |
| 33 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 45.7 |
| 34 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 45.7 |
| 35 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 45.7 |
| 36 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive | 31.4 |
| 37 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 31.4 |
| 38 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 31.4 |
| 39 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 31.4 |
| 40 | Cedars-Sinai CancerLos Angeles, CA | 31.4 |
| 41 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 31.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →